Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication

OBJECTIVES: After treatment failure with a tumor necrosis factor inhibitor (TNFi), patients with rheumatoid arthritis (RA) can switch to another TNFi (TNFi cyclers) or to a targeted disease-modifying antirheumatic drug (DMARD) with a non-TNFi mechanism of action (non-TNFi switchers). This study comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonafede, Machaon MK, Curtis, Jeffrey R, McMorrow, Donna, Mahajan, Puneet, Chen, Chieh-I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144914/
https://www.ncbi.nlm.nih.gov/pubmed/27980429
http://dx.doi.org/10.2147/CEOR.S115706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144914/
https://www.ncbi.nlm.nih.gov/pubmed/27980429
http://dx.doi.org/10.2147/CEOR.S115706

Ejemplares similares